IP Library Granted Patent US 8,602,033
Granted Patent B2
US 8,602,033 · App. 13/009,266 · Granted Dec 10, 2013

Methods for treating eye conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,602,033
App. No.
13/009,266
Granted
Dec 10, 2013
Kind
B2
Abstract

Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia. The treatments can affect at least one property of the eye and enhance an accommodation of the eye.

Claims (14)

1. A method for treating an eye having superior, medial, inferior and lateral rectus muscles, the eye being in need of one or more of a physiological and a vision correction, the method comprising:

projecting four patterns of tissue treatments onto portions of the eye, each of the four patterns comprising at least two tissue treatments and being disposed between a corresponding pair of adjacent ones of rectus muscles;

wherein tissue treatments are applied as perforations in a treatment zone between an inner radial dimension on the sclera coinciding with a limbus of the eye and an outer radial dimension on the sclera; and

wherein a distance between the inner radial dimension and the outer radial dimension ranges from about 5 mm to about 8 mm.

2. A method for treating an eye having superior, medial, inferior and lateral rectus muscles, the eye being in need of one or more of a physiological and a vision correction, the method comprising:

projecting four patterns of tissue treatments onto portions of the eye, each of the four patterns comprising at least two tissue treatments and being disposed between a corresponding pair of adjacent ones of rectus muscles;

wherein the tissue treatments are formed to depths between about 90% and 99% of a thickness of a sclera of the eye.

3. A method for treating an eye having superior, medial, inferior and lateral rectus muscles, the eye being in need of one or more of a physiological and a vision correction, the method comprising:

projecting four patterns of tissue treatments onto portions of the eye, each of the four patterns comprising at least two tissue treatments and being disposed between a corresponding pair of adjacent ones of rectus muscles;

wherein the tissue treatments comprise relatively small perforations ranging from about 1 micron to about 5 microns in diameter.

4. The method as set forth in claim 3 , wherein the tissue treatments are created with one or more of a micro-drill, a laser and a needle.

5. A method for treating an eye having superior, medial, inferior and lateral rectus muscles, the eye being in need of one or more of a physiological and a vision correction, the method comprising:

projecting four patterns of tissue treatments onto portions of the eye, each of the four patterns comprising at least two tissue treatments and being disposed between a corresponding pair of adjacent ones of rectus muscles;

wherein a maximum length dimension of each tissue treatment ranges from about 0.01 mm to about 1 mm, a maximum width dimension ranges from about 0.01 mm to about 1 mm, and a maximum depth dimension ranges from about 0.01 mm up to about 5 mm.

Assignments (6)
SECURITY INTEREST Recorded Oct 30, 2019
From: BIOLASE, INC.
To: PACIFIC MERCANTILE BANK
Reel/Frame 050879/0223 →
SECURITY INTEREST Recorded Nov 16, 2018
From: BIOLASE, INC.
To: SWK FUNDING LLC, AS AGENT
Reel/Frame 047588/0192 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2018
From: WESTERN ALLIANCE BANK
To: BIOLASE, INC.
Reel/Frame 048101/0027 →
SECURITY INTEREST Recorded Mar 7, 2018
From: BIOLASE, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 045514/0540 →
CHANGE OF NAME Recorded Nov 20, 2012
From: BIOLASE TECHNOLOGY, INC.
To: BIOLASE, INC.
Reel/Frame 029328/0096 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2011
From: JONES, JEFFREY W.; VAN VALEN, MARCIA ANGELA
To: BIOLASE TECHNOLOGY, INC.
Reel/Frame 025660/0532 →